Ocular Therapeutix Inc (NASDAQ:OCUL)

5.47
Delayed Data
As of Jan 26
 -0.16 / -2.84%
Today’s Change
5.18
Today|||52-Week Range
21.48
-21.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$422.9M

Company Description

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Contact Information

Ocular Therapeutix, Inc.
24 Crosby Drive
Bedford Massachusetts 01730
P:(781) 357-4000
Investor Relations:

Employees

Shareholders

Other institutional39.86%
Individual stakeholders29.64%
Mutual fund holders18.89%

Top Executives

Antony MattessichPresident, Chief Executive Officer & Director
Donald NotmanChief Financial Officer
Peter JarrettChief Scientific Officer
Michael H. GoldsteinChief Medical Officer & Ophthalmology President
Rabia Gurses OzdenSenior Vice President-Clinical Development